visualcamp-wins-future-innovators-award-at-gitex-2022-dubai

VisualCamp Wins Future Innovators Award at GITEX 2022 Dubai

 

VisualCamp (CEO Suk Yun-chan) , a member of the Born2Global Centre, an artificial intelligence (AI)-based eye-tracking technology startup, announced on October 19 that it won the Future Innovators Award at the Innovation Cup of GITEX 2022 held at the Dubai World Trade Center in Dubai, UAE, for three days October 10. This achievement proves the excellence of the company’s technology on the global stage once again. The event is an exhibition created to support the growth of startups at GITEX Global, the 42nd largest information and communication exhibition in the Middle East and Africa.

This year’s Innovation Cup is worth USD 175,000 in total prize money, and a total of 17 companies that passed the preliminary round were selected from among thousands of startups from all around the world. VisualCamp won the second-ranked Future Innovators Award and received USD 50,000 in credit. In addition, award-winning companies will receive various benefits such as Azure Credit of $1,500, support for participation in GITEX events, support for investment strategy consulting, marketing and SEO services, mentoring and investment networking opportunities, and media promotion. In this year’s event, a Korean startup won first place, and a Spanish startup won third place.

At the Innovation Cup, VisualCamp introduced “SeeSo,” an AI-based eye-tracking software solution that does not require separate hardware. This is an eye-tracking technology that anyone can easily experience through mobile devices such as smartphones and tablets anytime, anywhere and that overcomes the limitations of existing eye-tracking hardware devices. In addition to winning the Innovation Cup, VisualCamp’s eye-tracking technology has already been recognized worldwide with wins at the CES Innovation Awards and MWC Global Mobile Awards.

VisualCamp CEO Suk Yun-chan said, “I am happy that the eye-tracking technology developed by VisualCamp will once again be recognized at global exhibitions such as GITEX. We will use this award as a stepping stone to accelerate our entry into the Middle East and Africa markets.

hydraulic-hammer-market-to-reach-$34-billion,-globally,-by-2031-at-5.6%-cagr:-allied-market-research

Hydraulic Hammer Market to Reach $3.4 Billion, Globally, by 2031 at 5.6% CAGR: Allied Market Research

 

Allied Market Research published a report, titled, “Global Hydraulic Hammer Market by Product Type (Light Duty (upto 10 ton), Medium Duty (11-30ton), Heavy Duty (More than 31 ton)), by Business (OEM, Aftermarket), by End User Industry (Mining, Construction, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031″. According to the report, the global hydraulic hammer industry generated $2.0 billion in 2021, and is anticipated to generate $3.4 billion by 2031, witnessing a CAGR of 5.6% from 2022 to 2031.

Download Free Sample Report (240 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/3241

Prime determinants of growth

Increase in residential, and commercial construction, rise in population, and surge in demand for roads, highways, bridges, and tunnels drive the growth of the global hydraulic hammer market. However, lack of skilled and qualified operators restricts the market growth. Moreover, rise in government investments in infrastructure projects and mining sectors presents new opportunities in the coming years.

Covid-19 Scenario

  • The outbreak of the Covid-19 pandemic had a negative impact on the global hydraulic hammer market, owing to temporary closure of production of many products in the hydraulic hammer market during the global lockdown.
  • Furthermore, the number of COVID-19 cases reduced with the introduction of vaccines for COVID-19. This has led to the reopening of hydraulic hammer companies at their full-scale capacities, which is expected to help the market recover by the end of 2022.
  • In the post-pandemic period, hydraulic hammer manufacturers must focus on protecting their staff, operations, and supply networks to respond to urgent emergencies and establish new methods of working.

The heavy-duty (more than 31 tons) segment to maintain its leadership status throughout the forecast period

Based on product type, the heavy-duty (more than 31 tons) segment held the highest market share in 2021, accounting for more than two-thirds of the global hydraulic hammer market, and is estimated to maintain its leadership status throughout the forecast period. The sustainable manufacturing process and increased technology implementation in heavy construction equipment are the factors driving the growth of the segment. However, the light duty (up to 10 ton) segment is projected to manifest the highest CAGR of 7.6% from 2022 to 2031, as different light-duty hydraulic hammer equipment is highly adopted for construction and demolishment applications.

Buy this Research Report @ https://bit.ly/3EX5YwD

The aftermarket segment to maintain its leadership status throughout the forecast period

Based on business, the aftermarket segment held the highest market share in 2021, accounting for around three-fifths of the global hydraulic hammer market, and is estimated to maintain its leadership status throughout the forecast period. Moreover, the same segment is projected to manifest the highest CAGR of 6.0% from 2022 to 2031. The limited warranty period of parts & components and increase in the number of failures of machine operations & accidents are anticipated to fuel the growth of the hydraulic hammer aftermarket.

The mining segment to maintain its lead position during the forecast period

Based on end use industry, the mining segment accounted for the largest share in 2021, contributing to more than two-thirds of the global hydraulic hammer market, and is projected to maintain its lead position during the forecast period. This is owing to the fact that hydraulic hammers find extensive use in mining of valuable minerals or other geological materials from the earth. However, the construction segment is expected to portray the largest CAGR of 7.7% from 2022 to 2031. Rapid industrialization and urbanization in developing countries has led to the construction of new and luxurious offices and residential spaces in major cities of India and China. Such factors are fueling the segment growth.

Asia-Pacific to maintain its dominance by 2031

Based on region, Asia-Pacific held the highest market share in terms of revenue in 2021, accounting for nearly half of the global hydraulic hammer market, and is likely to dominate the market during the forecast period. Moreover, the same region is expected to witness the fastest CAGR of 6.6% from 2022 to 2031. Increase in spending capabilities, owing to ongoing mining and construction development in ChinaJapan and India. Furthermore, factors such as availability of workforce and low-cost manufacturing has fueled the manufacturing sector in the region. Other regions included in the report are North AmericaEurope, and LAMEA.

Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/3241

Leading Market Players: –

  • Atlas Copco
  • Breaker Technology Inc.
  • Caterpillar,
  • Everdigm,
  • Furukawa,
  • Indeco,
  • John Deere,
  • Miller UK,
  • MKB(KONAN),
  • Montabert,
  • MSB,
  • Sandvik,
  • Soosan heavy industries,
  • Stanley Hydraulics,
  • Volvo,
  • Nuosen Machinery,
  • Rammer

The report provides a detailed analysis of these key players of the global hydraulic hammer market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Trending Reports in Remote monitoring and Controls Industry (Book Now with 10% Discount):

Global tunnel boring machine market is expected to reach $7,552.1 million by 2027 | At a CAGR of 6.0%

Global mobile crane market is projected to reach $24.5 billion by 2031.

Cranes market size is expected to reach $41,186.63 million in 2027. At a CAGR of 4.8%

Construction equipment market is Projected to Reach $322.0 billion by 2031

Global mining equipment market is expected to reach $182,119 million by 2030

Global hydraulic equipment market size is expected to reach $51,653.1 million in 2027

Tunneling and Rock Drilling Equipment Market – Global Opportunity Analysis and Industry Forecast, 2022-2029

Hydraulic Marine Cranes Market – Opportunity Analysis and Industry Forecast, 2021-2030

mobileum-announces-miguel-carames-as-new-svp-for-roaming,-network-services-and-security

Mobileum Announces Miguel Carames as New SVP for Roaming, Network Services and Security

 

Mobileum, the leading global provider of telecom analytics solutions, announced today that Miguel Carames has joined the company and assumed the role of Senior Vice President (SVP) of Roaming, Network Services and Security. In this role, Carames will lead strategy and business execution for the Roaming and Security business units.

“We are delighted to have Miguel join the Mobileum team. His expertise in the industry is unmatched. As we continue to expand our offerings, Miguel’s understanding and leadership will be an asset in driving further success,” said Bobby Srinivasan, Mobileum CEO.

Most recently, Carames served as Executive Director of Cloud & Technology Planning at Verizon, where he was responsible for leading technology strategy and planning for Wireless Core (4G and 5G), Cloud, Multi-Access Edge Compute (MEC), Orchestration, and Emerging Technologies. While at Verizon, he also led teams in Network Operations & Engineering and Network Planning, as well as Product Development. Before joining Verizon, Miguel held senior roles in Engineering at Motorola.

Carames holds an MSc in Electrical Engineering from Universitat Politècnica de València (UPV), post-graduate credentials from Instituto Superior Técnico (Lisbon) and an MBA from the Jack Welch Management Institute.

nmims-hyderabad-appoints-dr.-siddhartha-ghosh-as-director

NMIMS Hyderabad appoints Dr. Siddhartha Ghosh as Director

 

NMIMS, Hyderabad appointed Dr. Siddhartha Ghosh as its new Director. In his 22 years of illustrious journey, Dr. Siddhartha Ghosh has been heading various departments with premier institutions in Hyderabad. He has been passionate about Institute Building, Human Resource Building, Leadership, L&D, Mentoring, Academic Research, Artificial Intelligence, Machine Learning and Deep Learning. A visionary, Dr. Siddhartha has mentored many professors and deans of various institutes and has been instrumental in shaping the careers of his students who have proved to be leaders in their respective domains.

Speaking on the appointment, Dr. Ramesh Bhat, Vice Chancellor, NMIMS, said, “We welcome Dr. Siddhartha Ghosh, an award-winning and globally recognized academician, and an educationist. We at NMIMS believe in having the best faculty and leadership to set a benchmark institution that transforms and created excellent talent globally. With over 2 decades of experience in R&D and AI and associated domains of Computer Science, we are delighted to have Dr. Siddhartha on board as a Director, of NMIMS Hyderabad. His excellence in multiple aspects of education will help the campus achieve the next level of innovation.”

Dr. Siddhartha Ghosh, Director of NMIMS Hyderabad Campus, said, “I am thrilled to be a part of this remarkable journey as a Director, of such an esteemed institution. I look forward to the support of the management as we move towards achieving to be the best Deemed-to-be University, the best B-School with multi-dimensional specializations. I believe that NMIMS stands to build its students as its marquee ambassadors and make a mark in the global landscape.”

Dr. Siddhartha has won accolades for co-authoring two books in addition to sixty-two national and international research publications.

artificial-intelligence-in-oncology-market-report-2022:-spending-on-ai-to-surpass-$110-billion-by-2024

Artificial Intelligence in Oncology Market Report 2022: Spending on AI to Surpass $110 Billion by 2024

 

The “Artificial Intelligence in Oncology Market: Distribution by Type of Cancer, Type of End-Users and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” report has been added to  ResearchAndMarkets.com’s offering.

Cancer is the one of the leading cause of deaths, globally, as per the World Health Organization (WHO). Annual statistics reported by the American Cancer Society (ACR) indicate that, in 2022, around 1.9 million individuals are likely to be diagnosed with various types of cancer in the US. During the same year, around 0.6 million cancer-related deaths are anticipated to be reported in the aforementioned region. In this context, it is important to highlight that, according to the International Agency for Cancer Research, by 2030, the number of cancer-related deaths is likely to rise by 72%.

This, in turn, is expected to result in an increase of 70% in the global cancer burden, over the next two decades. Amidst the ever growing cancer burden, a number of strategies are being tested by researchers and industry players to help provide relief to the affected individuals. In recent years, artificial intelligence (AI) has emerged as a key enabler in improving the accuracy and speed of cancer diagnosis.

Specifically, AI based cancer screening has resulted in reduced mortality rates of some prevalent malignancies. One of the most successful examples includes the detection of precancerous lesions, where timely treatment was demonstrated to considerably reduce the risk of malignant tumors. Consequently, several players engaged in the healthcare sector have incorporated AI powered technologies into their regular workflow to enable the identification of affected patients, thereby, ensuring timely treatment.

Given the various advantages offered by AI technology, players engaged in the pharmaceutical domain have developed AI in oncology-based software solutions for the treatment of a myriad of oncological indications. These solutions help in interpretation and integration of huge volumes of complex data. Further, an AI system lowers the diagnostic and treatment related errors that are likely to occur in human clinical practice, thereby, resulting in reduced testing costs.

Experts believe that there has been a significant rise in the revenue generation potential within this domain. This is further supported by the significant investments being made in this market. In fact, over the past five years, close to USD 6 billion has been invested in companies engaged in the development of AI in oncology-based software solutions.

Further, the global spending on AI is forecasted to grow to more than USD 110 billion by 2024. Considering the rising popularity of such solutions in the healthcare industry and the ongoing efforts of software providers to further improve / expand their respective offerings, we believe that the AI in oncology market is likely to evolve at a steady pace, till 2030.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET OVERVIEW

5. COMPANY PROFILES

6. COMPANY COMPETITIVENESS ANALYSIS

7. PATENT ANALYSIS

8. PARTNERSHIPS

9. FUNDING AND INVESTMENT ANALYSIS

10. BLUE OCEAN STRATEGY: A STRATEGIC GUIDE FOR START-UPS TO ENTER INTO HIGHLY COMPETITIVE MARKET

11. MARKET SIZING AND OPPORTUNITY ANALYSIS

12. CONCLUSION

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Companies Mentioned

  • 6 Dimensions Capital
  • 83North
  • 8VC
  • Affidea
  • Aidence
  • Aidoc
  • AIRA Matrix
  • Alexandria Venture Investments
  • AllianceBernstein
  • Ally Bridge Group
  • Ambra Health
  • AmCad BioMed
  • aMoon Fund
  • Amplify Partners
  • Ankur Capital
  • Apollo Hospital
  • Arterys
  • ARUP Laboratories
  • Asset Management Ventures
  • AstraZeneca
  • Athensmed
  • Atomico
  • Accelerating Technology Purposefully
  • AXA Venture Partners
  • Axilor Ventures
  • Baheya Foundation
  • Bain Capital Life Sciences
  • BankInvest
  • BEENEXT
  • Benslie Investment Group
  • BERG
  • BioAdvance
  • Biotheranostics
  • Blackford
  • Blue Pool Capital
  • Boehringer Ingelheim Venture Fund
  • Borski Fund
  • b-rayZ
  • Breyer Capital
  • BrightEdge
  • Bristol-Myers Squibb
  • British Business Bank
  • BVF Partners
  • C.L. David Foundation
  • Cambridge Capital Group
  • CancerCenter.ai
  • Canon Medical Systems
  • Capitol Health
  • Casdin Capital
  • Catalio Capital Management
  • Charles River Ventures
  • China Merchant Securities International
  • Colorectal Cancer Alliance
  • ConcertAI
  • Connect Ventures
  • Cormorant Asset Management
  • Cosmo Pharmaceuticals
  • Coutts
  • CPP Investments
  • Cornerstone Total Return Fund
  • CureMatch
  • CureMetrix
  • D.E. Shaw Research
  • D1 Capital Partners
  • Dana Farber Cancer Institute
  • Danhua Capital
  • Data Collective Venture Capital
  • Debiopharm Innovation Fund
  • Declaration Partners
  • Deep Bio
  • DeepHealth
  • DeepMind
  • Delin Ventures
  • Dell Technologies Capital
  • Densitas
  • DilenyTech
  • DocPanel
  • GenWorks Health
  • Global Ventures
  • Goldman Sachs
  • Google
  • GRAIL
  • Greycroft
  • Grove Ventures
  • Guardant Health
  • Guerbet
  • Hanfor Capital Management
  • Harmonix
  • Health Innovations
  • HealthCare Konnect
  • HealthQuest Capital
  • henQ
  • Hera-MI
  • HERAN Partners
  • Hillhouse Capital Group
  • Hina Group
  • Holland Capital
  • Hologic
  • Korea Health Industry Development Institute
  • Kinship Trust
  • KT Investment
  • Laerdal
  • LDPath
  • Legend Capital
  • Leica Biosystems
  • LEO Pharma
  • Lightpoint Medical
  • Liverpool Heart and Chest Hospital
  • Lucida Medical
  • Luminous Ventures
  • LungLife AI
  • Lunit
  • M Capital
  • Mamotest
  • Marubeni Corporation
  • MassMutual Ventures
  • Maverick Ventures
  • Median Technologies
  • Medical EarlySign
  • Medicover
  • MediPath
  • Medtronic
  • Memorial Sloan Kettering Cancer Center
  • Merck
  • Polaris Partners
  • Prodeko Ventures
  • Prognica Labs
  • Proscia
  • PSP Investments
  • Qingsong Fund
  • Qlarity Imaging
  • Quantib
metrostar-announces-ai/ml-operator-and-investor-as-advisory-board-member

MetroStar Announces AI/ML Operator and Investor as Advisory Board Member

 

MetroStar is pleased to announce Ryan Lewis as a newly appointed Advisory Board Member, focusing on the organization’s pathway to developing and maintaining successful artificial intelligence (AI) and machine learning (ML) solutions.

Lewis is a Partner at SRI Ventures—the corporate venture arm of SRI International—a nonprofit research and development institute, where he focuses on investing in early-stage AI/ML and deep tech companies with an interest in developing dual-use offerings.

“As we look to the future of the industry and our solutions, we are excited to align ourselves with experts like Ryan who offer dynamic insights into building innovative solutions that protect our Nation,” said Vy Truong, MetroStar’s Chief Innovation Officer.

Before joining SRI Ventures, Lewis was the Senior Practice Manager of AI/ML for Amazon Web Services National Security, where he led teams building AI/ML applications for national security organizations. He has also held the Senior Vice President role at In-Q-Tel, where he co-founded an AI/ML research lab focused on computer vision techniques. His team published and presented papers on Neural Information Processing Systems and Computer Vision and Pattern Recognition at leading AI/ML conferences.

Furthermore, Lewis co-founded and worked as the General Manager of SpaceNet, a nonprofit industry consortium designed to accelerate open-source applied AI research for geospatial applications. He led the organization to produce numerous datasets and competitions, targeting 3,000 competitors across 30+ countries.

“The rapid industrialization of AI/ML capabilities is prompting adopters to rethink their technology strategies to achieve scale while managing cost and performance. MetroStar’s dedication to supporting and integrating AI/ML open-source projects into their solutions and engagements can provide customers the flexibility to leverage innovations,” said Lewis.

Lewis is well-versed in both public and private sector markets, and his experience with AI/ML technologies across industries will guide MetroStar as the company navigates the changing data needs and solutions customers face daily.

navignostics-selects-celegence’s-captis-technology-solution-to-support-ivdr-compliance

Navignostics Selects Celegence’s CAPTIS™ Technology Solution to Support IVDR Compliance

 

Celegence, a global provider of regulatory affairs services for the life sciences industry, is pleased to announce that Navignostics, a global developer of drug mechanisms designed to identify ideal treatments for cancer patients, has selected Celegence’s CAPTIS™ technology solution to support Performance Evaluation Reports and other PMS documentation in compliance with the In-Vitro Diagnostic Regulation (IVDR).

Navignostics has been working dedicatedly to leverage unique tumor analysis approaches to improve personalized diagnostics for cancer patients. With highly robust and reliable technology and leading data analytics, Navignostics aims to deliver the optimal cancer treatment for each patient and provide services to pharma and biotech partners.

As the EU’s IVDR directives went into effect this year, diagnostic manufacturers are now pressed by the complex literature review and data management activities required to write PMS documentation to remain compliant. Celegence’s CAPTIS™ cloud solution provides integration with literature and safety databases to automate the creation of PMS documentation, such as Performance Evaluation Reports and Post Market Surveillance Reports. The solution also provides report writing and document management capabilities, which help in the creation and ongoing maintenance of various reports.

Punya Abbhi, Chief Operating Officer at Celegence, said: “We are so glad to support Navignostics in the process of EU IVDR PMS documentation. The CAPTIS™ system will create significant time savings for Navignostics’ medical writing process by reducing manual efforts and helping writers organize and analyze data more seamlessly.”

“Navignostic’s mission of designing client-oriented personalized solutions resonates with our values. Celegence realizes our client’s unique demands, and we aspire to provide efficient planning and cost-effective solutions through our innovative technologies.”

Dr. Stéphane Chevrier, Co-Founder at Navignostics, said: “We are genuinely excited to work with Celegence and use CAPTIS™ for our IVDR documentation, including literature reviews. I believe the CAPTIS™ platform can better support our compliance efforts related to launching and maintaining focused cancer treatments and medications.”

If you would like to learn more about how CAPTIS™ can help organization with regulatory compliance, please contact a Celegence representative today at [email protected]. Celegence’s expert team is also attending the MedTech Summit US on December 6-8, 2022, at the Intercontinental Chicago Magnificent Mile, Chicago, so please come by the stand – 2 if you are in the area.

fimatix-partners-with-regtech-firm-corlytics-in-next-stage-of-enhanced-private-sector-offering

Fimatix partners with regtech firm Corlytics in next stage of enhanced private sector offering

 

Through this partnership, the two firms will integrate each other’s services into their own offerings, creating a combined suite of products and solutions capable of augmenting regulation and change management systems across the financial services and insurance sectors.

Its partnership with Corlytics follows Fimatix’s recent expansion of its private sector practice, including the appointment of Sanjeev Dhiman as Chief Business Officer for Private Sector Business and the acquisition of Idea Group in May.

Corlytics’ risk intelligence solutions join Fimatix’s governance and reporting tool Prodigy, information interaction service Nova, AI data manager Jaid, and outsourced recruitment tool Talent as a Service (TaaS). The partnership strengthens Fimatix’s wider digital transformation offering, which enables organisations to expertly accelerate their digital development.

Fimatix CEO Tim Howarth said of the partnership:

“I have worked with Corlytics since 2014, we share a passion for putting technology at the heart of compliance.  With the team at Fimatix we’ve become well-acquainted with Corlytics’ innovation, expertise, and state of the art regtech products. It has been impressive to see Corlytics’ journey so far, and we are excited to be included in that as a formal partner in the future.

“I believe that together we can make significant improvements in risk and compliance effectiveness, benefitting organisations and end users throughout the financial services industry.  As ESG compliance increases in intensity there is huge demand for more efficient regulatory solutions and Corlytics has been leading this charge.”

Corlytics CEO John Byrne said:

“We have been partnering with Fimatix since both companies’ inception, working on transforming operating models essential in digitising the regulatory monitoring and change management processes at large financial services firms.

“Fimatix’s rapid rise reflects the success of its clients in embracing change in digitising their businesses, and we are excited to be working with them in partnership. We believe that the Fimatix’s Digital Transformation Experience and Capabilities can help customers to adopt our advanced regulatory technology, such that new ways of working, new operating models and new technology are fully adopted, used and deliver the value promised by these new technologies.”

ineo-extends-intellectual-property-protection-with-global-patent-cooperation-treaty

INEO Extends Intellectual Property Protection with Global Patent Cooperation Treaty

 

INEO Tech Corp. (TSXV: INEO) (OTCQB: INEOF) (the “Company” or “INEO“), the innovative developer and operator of the INEO Media Network, a digital advertising and analytics solution for retailers, today announced it made a Patent Cooperation Treaty (PCT) filing for global intellectual property protection.

INEO recently filed for a design patent in Canada for its “INEO WELCOMING GATE” system, a companion system to the INEO Welcoming Pedestal. This patent has now been extended with a global priority filing to include the United States and Europe.

“INEO’s intellectual property strategy is keeping us in an industry leading position which is far ahead of the competition,” said Greg Watkin, Chairman and President of INEO. “We are well into the monetization strategy of our patents and products, and we feel very comfortable that we are well ahead of other, larger industry players. Our patent portfolio is diverse and provides significant protection should our competitors create similar technology or products. Furthermore, we are very pleased with our global partner, Prosegur, who has agreed to help protect and defend our patents as we extend our lead and displace the competition in major retailers around the world.”

INEO was granted a core utility patent for the combination of Digital Media display screen and Electronic Article Surveillance (EAS) loss prevention technology integration in the U.S. (patent 10,614,691), Canada (patent 2,936,044) and Europe (patent 3482377). These patents prevent any other Electronic Article Surveillance (EAS) provider from selling an EAS system which contains a digital media display screen, leaving the INEO Welcoming System as the only system on the market which can combine advertising and loss prevention in one form factor.

The design patent, “INEO Welcoming GATE” is used as a companion product that can be paired with an INEO Welcoming System, ideally deployed at retail location where there are multiple doors at the front entrance. The INEO Welcoming GATE’s bold, sleek design, with its customizable branding, gives the entrance of the retail store a fresh look. When combined with an INEO Welcoming Pedestal it also provides unmatched visual appeal. Protecting the innovation of this design is essential to INEO’s competitive edge. The INEO Welcoming GATE utilizes technology INEO designed for the INEO Welcoming System which allows it to operate in both the Accousto-Magnetic (AM) 58KHz frequency spectrum and the 8.2MHz frequency spectrum.

INEO’s patented technology combines traditional Electronic Article Surveillance (EAS) systems with a digital media display in one integrated device. EAS systems are theft prevention devices which are typically found at the entrance or exit of a retail store and transmit a radio frequency (RF) signal which detects tags and labels on products. The combination of a media display and EAS system is a non-trivial and unique invention due to the complexity in designing and housing a RF security tag system in close proximity to a media display screen without degradation of the required RF signal.  This patented technology drives INEO’s business model of integrating retail digital signage with retail media networks to generate SaaS (Software-as-a-Service) based revenue.

palantir-announces-new-distinguished-members-to-federal-advisory-board

Palantir Announces New Distinguished Members to Federal Advisory Board

 

Palantir Technologies Inc. (NYSE: PLTR) announced four new additions to its Palantir Federal Advisory Board (PFAB). The additions will bring expert perspectives to the Advisory Board on critically important issues, such as addressing public health infrastructure, managing the challenges associated with supply chain and logistics, and supporting national security missions, enabling Palantir to continue to meet the evolving and complex needs of its United States Government (USG) partners.

New members of the Advisory Board are:

  • Dr. Deborah L. Birx, Former Coordinator of the White House Coronavirus Task Force, and Former Ambassador-at-Large of the President’s Emergency Plan for AIDS Relief (PEPFAR) Program to support HIV/AIDS Treatment and Prevention
  • The Honorable Will Hurd, Former Representative of Texas’ 23rd District
  • General Gustave F. Perna, USA (Retired), Former Chief Operating Officer, Operation Warp Speed; Former Commander, Army Materiel Command (AMC), U.S. Department of Defense
  • Mr. Greg Simon, Former Executive Director of the White House Cancer Moonshot Task Force and the Biden Cancer Initiative, and Co- Founder of the Melanoma Research Alliance

Palantir created its Federal Advisory Board earlier this year to bring unparalleled expertise to its government operations. These additions expand that mission with decades of first-hand experience facing America’s most urgent threats in public health, supply chain and logistics, and national security. They bring an acute understanding of the difference cutting edge technologies – and companies like Palantir – can make to address this country’s most pressing issues.

“Our work with the United States government, including its defense and intelligence agencies as well as the public health sector, remains at the center of our company,” said Alexander C. Karp, co-founder and chief executive officer of Palantir Technologies Inc. “We are honored to partner with the newest members of our advisory board, whose work has shaped national policy on the most pressing challenges that we collectively face.”

Palantir’s valued partnerships with the US Government, coupled with its mission-driven commitment, have generated an increase in demand for Palantir’s operating system across a multitude of federal agencies. 
“Adding these experienced leaders to the advisory board helps Palantir gain additional perspectives and insight on how we can leverage best in class commercial software to improve outcomes for our customers and our country,” said Akash Jain, President of Palantir USG.

Whether assisting in a public health crisis, helping plan for disaster readiness, or supporting the national security of our country and its allies, Palantir delivers cutting-edge technology to the government in numerous value add ways. In an era of rapidly evolving challenges, decision-makers need vital software capabilities that more often than not come from the commercial marketplace.